Brazil Issues Patent for Potential Zika Treatment
Isla Pharmaceuticals, a Puerto Rico based company, announced on October 20, 2020, that a key patent relating to Isla101 has been granted by the Brazilian Industrial Property Office. Isla101, a drug with a well-understood safety profile, is being repurposed for the potential prevention and treatment of mosquito-borne diseases and has been in approximately 40 clinical trials for other indications.
Dr. Paul MacLeman commented in a press release, "The grant of the Brazilian patent is a significant development for the company as mosquito-borne viruses, such as dengue, Zika and others represent major unmet medical needs in Brazil."
Brazil has been severely affected by outbreaks of Zika virus.